The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females.
about
Residual macrovascular risk in 2013: what have we learned?Uncovering Factors Related to Pancreatic Beta-Cell FunctionImpact of admission triglyceride for early outcome in diabetic patients with stable coronary artery disease.The atherogenic index of plasma and the risk of mortality in incident dialysis patients: Results from a nationwide prospective cohort in Korea.Impact of serum triglyceride and high density lipoprotein cholesterol levels on early-phase insulin secretion in normoglycemic and prediabetic subjects.Urban-rural differences in atherogenic dyslipidaemia (URDAD Study): a retrospective report on diabetic and non-diabetic subjects of Northern India.The association between triglyceride/high-density lipoprotein cholesterol ratio and all-cause mortality in acute coronary syndrome after coronary revascularization.The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney diseaseThe association of hematologic inflammatory markers with atherogenic index in type 2 diabetic retinopathy patientsAssociations between branched chain amino acid intake and biomarkers of adiposity and cardiometabolic health independent of genetic factors: A twin study.Making sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction.Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease.Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids.Functional and Structural Impact of ATP-Binding Cassette Transporter A1 R219K and I883M Gene Polymorphisms in Obese Children and Adolescents.The mixed benefit of low lipoprotein(a) in type 2 diabetes.How to transform a metabolic syndrome score into an insulin sensitivity value?The MicroRNA Interaction Network of Lipid Diseases.[HDL-C/apoA-I]: A multivessel cardiometabolic risk marker in women with T2DM.Characterization of Ageing- and Diet-Related Swine Models of Sarcopenia and Sarcopenic Obesity.Risk of Microangiopathy in Patients with Epilepsy under Long-term Antiepileptic Drug Therapy.
P2860
Q26996039-762A7E2A-494B-4416-8074-60B5256DCFAFQ28553583-0DAADA17-1EC4-4D01-A5E1-0E4D89BE3944Q33580249-8206B455-ED71-4470-B73C-8291FC4911D0Q33732285-88985D2C-E1BC-4649-A4C6-E6C1F2BBD07AQ34161905-FB4DB312-952F-4109-9B95-82858E9E06E1Q34458547-8D3B7A71-8BDC-423B-AFAE-E98C1EFD4BEDQ35447178-5C6E1579-6198-40C2-BB20-E27A23F14E46Q35530832-A3FBF284-8E97-4358-B292-55B388A927BAQ37276729-A8483D8A-C3A2-4D08-A7EB-B200BC113F8FQ37356958-644D2567-DCED-4DFE-BBD0-E95C05634B41Q37393027-419765DD-E436-43DB-AE77-6854DD3610CEQ37670674-6B33BBA6-A927-4784-9122-EDAAFC3224DAQ37683866-4ACD6277-8AA9-4F69-BB56-E7D02A2BD3B5Q40660185-7E044845-B35A-454E-A42D-001B0ABF1241Q41151540-8DF06D78-106C-4D2B-B6FB-B92B1A9B0E0FQ41641381-3C2EA6F7-EE8A-4FC6-B2F6-C8B99A6A0DE0Q42085671-F4CDD675-49F5-4686-8C5B-851C13FBD652Q48331580-C5713673-315F-4DC7-9632-43764C458FBDQ51763545-E102E792-D8E1-4694-9DB2-501FC7143043Q55037428-4CB5078D-EE01-458B-80ED-1B4397C26007
P2860
The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The atherogenic dyslipidemia r ...... hy in type 2 diabetes females.
@ast
The atherogenic dyslipidemia r ...... hy in type 2 diabetes females.
@en
type
label
The atherogenic dyslipidemia r ...... hy in type 2 diabetes females.
@ast
The atherogenic dyslipidemia r ...... hy in type 2 diabetes females.
@en
prefLabel
The atherogenic dyslipidemia r ...... hy in type 2 diabetes females.
@ast
The atherogenic dyslipidemia r ...... hy in type 2 diabetes females.
@en
P2093
P2860
P921
P356
P1476
The atherogenic dyslipidemia r ...... hy in type 2 diabetes females.
@en
P2093
Michel F Rousseau
Michel P Hermans
Sylvie A Ahn
P2860
P2888
P356
10.1186/1476-511X-11-132
P577
2012-10-09T00:00:00Z
P5875
P6179
1013423905